Sibel Health is an award-winning digital health company based in Chicago, with an international presence in Seoul. The company specializes in developing advanced wearable sensors and AI-enabled data analytics through its FDA-cleared ANNE® platform, which integrates with mobile devices for continuous monitoring and alerting of vital signs. Sibel Health's Discovery platform is utilized by leading pharmaceutical companies for continuous data collection in home settings for clinical trials, aiming to transform healthcare with real-world health data integration.
Sibel Health LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Sibel Health had 103 employees as of October 12, 2026. The number of employees increased by 1 (0.98%) week-over-week.
Sibel Health had 19,619 followers as of October 12, 2026. The number of followers increased by 43 (0.22%) week-over-week.
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 30, 2025 | Series C | $9.00M | ― |
| Oct 14, 2025 | Series C | $39.00M | ― |
| Investor Name | Funding Round |
|---|---|
| Samsung Next | Series C (2) |
| Maruho Co., Ltd. | Series C (2) |
| Dräger | Series C |
| Steele Foundation for Hope | Series C |
A snapshot of private companies similar to Sibel Health, helping you discover and navigate related company profiles.



